Warning! GuruFocus detected
1 Severe warning sign
with LADX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
LadRx Corp
NAICS : 325414
SIC : 2836
ISIN : US2328286081
Description
LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -1.69 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 22.8 | |||||
| 3-Year EPS without NRI Growth Rate | 40.8 | |||||
| 3-Year FCF Growth Rate | 56.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.88 | |||||
| 9-Day RSI | 22.44 | |||||
| 14-Day RSI | 26.97 | |||||
| 3-1 Month Momentum % | 11.26 | |||||
| 6-1 Month Momentum % | 5 | |||||
| 12-1 Month Momentum % | -19.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.37 | |||||
| Quick Ratio | 0.37 | |||||
| Cash Ratio | 0.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -125.45 | |||||
| ROIC % | -7839.83 | |||||
| 3-Year ROIIC % | -445.56 | |||||
| ROC (Joel Greenblatt) % | -36959.18 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | 0.38 | |||||
| EV-to-EBITDA | 0.39 | |||||
| EV-to-FCF | 1.07 | |||||
| Earnings Yield (Greenblatt) % | 263.16 | |||||
| FCF Yield % | -203.57 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LADX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LadRx Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.21 | ||
| Beta | 0.31 | ||
| 3-Year Sharpe Ratio | -0.09 | ||
| 3-Year Sortino Ratio | -0.16 | ||
| Volatility % | 198.2 | ||
| 14-Day RSI | 26.97 | ||
| 14-Day ATR ($) | 0.064452 | ||
| 20-Day SMA ($) | 1.589 | ||
| 12-1 Month Momentum % | -19.23 | ||
| 52-Week Range ($) | 0.4621 - 3.5 | ||
| Shares Outstanding (Mil) | 0.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LadRx Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LadRx Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
LadRx Corp Frequently Asked Questions
What is LadRx Corp(LADX)'s stock price today?
The current price of LADX is $1.30. The 52 week high of LADX is $3.50 and 52 week low is $0.46.
When is next earnings date of LadRx Corp(LADX)?
The next earnings date of LadRx Corp(LADX) is 2025-05-15 Est..
Does LadRx Corp(LADX) pay dividends? If so, how much?
LadRx Corp(LADX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers